FDA approves first twice-yearly injection that prevents HIV infection
|
The FDA has approved Yetzugo, Gilead Sciences'
twice-yearly injectable HIV prevention treatment, which showed nearly
100% effectiveness in ... |
Beetle-powered TB test aids diagnosis in HIV patients
A credit card-sized tuberculosis test that works without electricity has shown 87 per cent accuracy in detecting TB among people living with HIV . View article...